Optimal follow-up to curative colon and rectal cancer surgery: How and for how long?

Theodor Asgeirsson, Sen Zhang, Anthony J. Senagore

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In 2009, the projected incidence for colon and rectal cancers in the United States was 106,100 and 40,870, respectively, and approximately 75% of these patients were treated with curative intent. Surveillance or follow-up after colon and rectal cancer resection serves multiple purposes; however, the primary argument supporting the validity of surveillance is the detection of metachronous and recurrent cancers amenable to curative treatment. The surveillance may provide some comfort for cancer survivors who can be informed that they have no evidence of disease.

Original languageEnglish (US)
Pages (from-to)861-873
Number of pages13
JournalSurgical Oncology Clinics of North America
Volume19
Issue number4
DOIs
StatePublished - Oct 2010
Externally publishedYes

Fingerprint

Rectal Neoplasms
Colonic Neoplasms
Survivors
Neoplasms
Incidence
Therapeutics

Keywords

  • Colon cancer
  • Follow-up
  • Rectal cancer
  • Surveillance

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Optimal follow-up to curative colon and rectal cancer surgery : How and for how long? / Asgeirsson, Theodor; Zhang, Sen; Senagore, Anthony J.

In: Surgical Oncology Clinics of North America, Vol. 19, No. 4, 10.2010, p. 861-873.

Research output: Contribution to journalArticle

Asgeirsson, Theodor ; Zhang, Sen ; Senagore, Anthony J. / Optimal follow-up to curative colon and rectal cancer surgery : How and for how long?. In: Surgical Oncology Clinics of North America. 2010 ; Vol. 19, No. 4. pp. 861-873.
@article{55adf64b66974532ba6b4d0499aa8c34,
title = "Optimal follow-up to curative colon and rectal cancer surgery: How and for how long?",
abstract = "In 2009, the projected incidence for colon and rectal cancers in the United States was 106,100 and 40,870, respectively, and approximately 75{\%} of these patients were treated with curative intent. Surveillance or follow-up after colon and rectal cancer resection serves multiple purposes; however, the primary argument supporting the validity of surveillance is the detection of metachronous and recurrent cancers amenable to curative treatment. The surveillance may provide some comfort for cancer survivors who can be informed that they have no evidence of disease.",
keywords = "Colon cancer, Follow-up, Rectal cancer, Surveillance",
author = "Theodor Asgeirsson and Sen Zhang and Senagore, {Anthony J.}",
year = "2010",
month = "10",
doi = "10.1016/j.soc.2010.06.003",
language = "English (US)",
volume = "19",
pages = "861--873",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Optimal follow-up to curative colon and rectal cancer surgery

T2 - How and for how long?

AU - Asgeirsson, Theodor

AU - Zhang, Sen

AU - Senagore, Anthony J.

PY - 2010/10

Y1 - 2010/10

N2 - In 2009, the projected incidence for colon and rectal cancers in the United States was 106,100 and 40,870, respectively, and approximately 75% of these patients were treated with curative intent. Surveillance or follow-up after colon and rectal cancer resection serves multiple purposes; however, the primary argument supporting the validity of surveillance is the detection of metachronous and recurrent cancers amenable to curative treatment. The surveillance may provide some comfort for cancer survivors who can be informed that they have no evidence of disease.

AB - In 2009, the projected incidence for colon and rectal cancers in the United States was 106,100 and 40,870, respectively, and approximately 75% of these patients were treated with curative intent. Surveillance or follow-up after colon and rectal cancer resection serves multiple purposes; however, the primary argument supporting the validity of surveillance is the detection of metachronous and recurrent cancers amenable to curative treatment. The surveillance may provide some comfort for cancer survivors who can be informed that they have no evidence of disease.

KW - Colon cancer

KW - Follow-up

KW - Rectal cancer

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=77957130015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957130015&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2010.06.003

DO - 10.1016/j.soc.2010.06.003

M3 - Article

C2 - 20883959

AN - SCOPUS:77957130015

VL - 19

SP - 861

EP - 873

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 4

ER -